On the basis of our observations and the recognized cooperative interactions between PRL and ER signaling in breast cancer (24, 25), we hypothesized that inadequacy of the PRL/PRLR signaling axis is a major contributing cause of the poor human-in-mouse engraftment rates of ER+ PDX models. This evidence concerns the gene PRLR and breast cancer.